APA

Vidal A. D., Thalmann G. N., Karamitopoulou-Diamantis E., Fey M. F. & Studer U. E. (20160224). Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Vidal A D, Thalmann G N, Karamitopoulou-Diamantis E, Fey M F and Studer U E. 20160224. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Vidal A. D., Thalmann G. N., Karamitopoulou-Diamantis E., Fey M. F. and Studer U. E. (20160224). Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Vidal A D, Thalmann G N, Karamitopoulou-Diamantis E, Fey M F and Studer U E. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology. 20160224.